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Abstract
Background: Within the context of a European network dedicated to the study of sarcoma the relevant literature on 
sarcoma risk factors was collected by searching PubMed and Google Scholar, the two information storage and retrieval 
databases which can be accessed without charge. The present study aims to appraise the relative proficiency of 
PubMed and Google Scholar.
Findings: Unlike PubMed, Google Scholar does not allow a choice between "Human" and "Animal" studies, nor 
between "Classical" and other types of studies. As a result, searches with Google Scholar produced high numbers of 
citations that have to be filtered. Google Scholar resulted in a higher sensitivity (proportion of relevant articles, meeting 
the search criteria), while PubMed in a higher specificity (proportion of lower quality articles not meeting the criteria, 
that are not retrieved). Concordance between Google Scholar and PubMed was as low as 8%.
Conclusions: This study focused just on one topic. Although further studies are warranted, PM and GS appear to be 
complementary and their integration could greatly improve the search of references in medical research.
Introduction
Within the context of a European network dedicated to
the study of sarcoma, all incident cases have been col-
lected for two years from the Pathology Departments of
three European regions: Rhone-Alpes and Aquitaine in
France and Veneto in Italy. All diagnoses of sarcoma were
reviewed by the regional expert pathologist, and molecu-
lar subtypes were identified when possible. To find
hypotheses that could be used to design a case-control
study on risk factors for sarcoma, we collected the rele-
vant literature by searching PubMed (PM) and Google
Scholar (GS), the two information storage and retrieval
databases which can be accessed without charge. The
general characteristics of these search facilities have been
recently presented [1-4]. The present study aims to
appraise the relative proficiency of the two search
engines.
Methods
This is a study on concordance, sensitivity, specificity and
accuracy of PM and GS in returning articles published
between 2002 and 2009 on risk factors for sarcoma. The
starting year was chosen because in late 2002 the World
Health Organization published a new classification of
sarcoma that gained widespread acceptance [5].
The papers shared by PM and GS - when adopting the
same keywords and limits - were used to calculate a mea-
sure of concordance. Sensitivity, specificity and accuracy
were assessed by using different searching strategies. The
first was designed to be more sensitive and less specific: it
was broader and could include both descriptive (ecologi-
cal or clinical case series) and analytical (case control or
cohort) epidemiological studies. The second strategy was
instead more specific but less sensitive, focusing mainly
on epidemiological analytical studies.
With two search engines (PM and GS) and two search
strategies, there were four scenarios: GS1; GS2; PM1;
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Page 2 of 4• GS1 started choosing all articles reporting the words
"sarcoma", "incidence", and "case" (see string 1 in the box).
Studies published before 2002 were excluded by using a
special tool of GS. The list of papers was printed. In order
to eliminate experimental animal studies and clinical
studies on therapy and prognosis, retrieved articles pre-
senting words such as "prognosis", "treat", "surg", "ther-
apy", "efficacy", "survival", "chemotherapy", "mussel",
"bivalve", "dog", "veterin", "cat", "feline", "bird", "avian",
"fish", "mice", "rat", "mouse", "guinea", "rabbit", "ocean",
"Kaposi's", "osteosarcoma", "Rous" (see string 2 in the box)
were removed, but only after reading the title. Among the
remaining articles, those not reporting "sarcoma" in the
title or abstract, or being citations of books, abstract con-
ferences, letters to the editor, or editorials were dis-
carded. Interface was English, but pages written in any
tongue were searched. Papers in language other than
English were eventually ruled out.
• GS2 used the same search method as GS1, except that
the searched terms were "sarcoma", "incidence", "case",
and "risk" (see strings 3 and 4 in Additional file 1: Box).
• PM1 started by selecting articles reporting the words
"sarcoma", "incidence", and "case" (see string 5 in the box).
Furthermore, the following "Limits" were chosen:
"Humans"; "English language"; "Classical article" as type
of article; and "January 1st 2002 - April 22th 2009 as spe-
cific date range. After printing the list, the papers were
scrutinized for the words "prognosis", "treat", "surg",
"therapy", "efficacy", "survival", "chemotherapy",
"Kaposi's", "osteosarcoma", "Rous" (see string 6 in box).
Again, the same "Limits" as above were applied. The
remaining articles were inspected for the presence of the
word "sarcoma" in either the title or the abstract and
those not reporting "sarcoma" in the title or the abstract
were discarded. Clinical studies on diagnosis/therapy/
prognosis were eventually discarded.
• PM2 used the same search method as in PM1, except
that the searched terms were "sarcoma", "incidence",
"case", and "risk" (see strings 7 and 8 in Additional file 1:
Box).
After abstract selections were agreed upon, the filtered
papers were evaluated by two independent reviewers in
order to establish whether the risk factors for sarcoma
were investigated or not. In the latter instance papers
were mainly case reports or described new diagnostic
devices (e.g. molecular biology or imaging techniques).
Disagreements between reviewers concerning classifica-
tion of articles were resolved by discussion and input
from a third reviewer. Finally, the whole number of 168 (=
63+42+46+17) studies collected was reduced to 111
(common list) by excluding those shared by the parent
lists GS1, GS2, PM1, and PM2.
Statistical analysis
The common list was broken down into a series of two-
by-two tables, in which columns were headed "Yes RF"
and "No RF" - depending on whether the risk factors (RF)
for sarcoma were or were not investigated - and rows
were GS1 (or, in turn, GS2, PM1, PM2) and the remaining
sources altogether. In such tables we calculated sensitiv-
ity, specificity, precision and accuracy.
The sensitivity for a given strategy is defined as the pro-
portion of articles retrieved that are scientifically sound
and clinically relevant (high quality articles); specificity is
the proportion of lower quality articles (did not meet cri-
teria) that are not retrieved; precision is the proportion of
retrieved articles that meet criteria (equivalent to positive
predictive value in diagnostic test terminology); and
accuracy is the proportion of all articles that are correctly
dealt with by the strategy (articles that met criteria and
were retrieved plus articles that did not meet criteria and
were not retrieved divided by all articles in the database)
[6].
The common list was also broken down to show papers
shared by pairs of bibliographic sources (GS 1 and GS2;
PM1 and PM2; GS and PM) that used the same key words
and limits. The agreement between pairs was calculated
using the Dunn's method [7].
Results
Figure 1 shows a flow diagram of the exclusion criteria
applied to the articles retrieved by GS1. Out of the initial
755 items returned by GS1, approximately 90% were dis-
carded for the following differing reasons: 9% (= 70/755)
were excluded because they were animal experimental
studies or human clinical ones; 80% (= 610/755) were
excluded because the word "sarcoma" was mentioned in
the Introduction, Discussion or References (but not in the
Title or Abstract) or because citations concerned publica-
tions such as editorials, books, letters to editors, confer-




70 articles on experimental or clinical studies 
610 articles where “sarcoma” was not mentioned in 
title or abstract, books, conferences, letters to editor, 
editorials. 
75 
12 articles published before 2002, or 
in language other than English 
63 
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Page 3 of 4ences, posters, etc.; 2% (= 12/755) because the language
was not English. The number of the remaining relevant
papers was 63.
Figure 2 shows a flow diagram of the exclusion criteria
applied to the articles retrieved by GS2. Out of the initial
437 items returned by GS2, approximately 91% were dis-
carded for the following reasons: 9% (= 39/437) were
excluded because they were animal experimental studies
or human clinical ones; 75% (= 327/437) were rejected
because the word "sarcoma" was mentioned in the Intro-
duction, Discussion or References (but not in the Title or
Abstract) or because citations concerned publications
such as editorials, books, letters to editors, conferences,
posters, etc.; 8% (= 33/437) because the language was not
English. The number of the remaining relevant papers
was 34.
Figure 3 shows a flow diagram of the exclusion criteria
applied to the articles retrieved by PM1: the initial num-
ber returned by PM1 (68) was remarkably smaller than
that provided by GS1 (755) and GS2 (437). 12% (= 8/68)
of articles were excluded because they did not report
"sarcoma" in the Title or Abstract; 21% (= 14/68) were
ruled out as being clinical studies. The final number of
relevant articles was 46, 68% (= 46/68) of the initial num-
ber.
Figure 4 shows a flow diagram of the exclusion criteria
applied to the articles retrieved by PM2: the initial num-
ber returned by PM2 (25) was remarkably smaller than
that provided by GS1 (755) and GS2 (437). 20% (= 5/25)
of articles were excluded because they did not report
"sarcoma" in the Title or Abstract; 12% (= 3/25) were
ruled out as being clinical studies. The final number of
relevant articles was 17, 68% (= 17/25) of the initial num-
ber.
The Additional File 1: Table S1 shows that, as expected,
GS2 and PM2 were more specific, precise and accurate
strategies than GS1 and PM1. Furthermore GS was more
sensitive yet less specific as compared to PM. The two
search engines showed similar precision and accuracy.
Additional file 1: Table S2 shows that the agreement
between pairs of bibliographic sources was poor, espe-
cially in the comparison between GS and PM, where this
concordance was as low as 8%.
Discussion
A possible limitation of this study is the decision to
exclude articles written in language other than English,
thus ruling out items written in different language that
could provide relevant information for systematic reviews
of the literature. Papers written in languages other than
English were discarded because they could be published
in journals not indexed in PM; nevertheless these items
could be found in GS as its inclusion criteria are obscure.
Another possible limitation of this study is that it
focused just on one topic. However, our methodology of
checking the retrieved articles - one by one - is hardly
applicable to other medical research fields where GS
could browse and return up to several hundred thousands
of papers. Despite the difficulty in predicting the external
validity of our results, we believe that our findings might
be reasonably applied to other biomedical subjects.
In our study GS returned more results than PM, but
most citations were unnecessary. Roughly 80% of cita-




39 articles on experimental or clinical studies 
327 articles where “sarcoma” was not mentioned 
in title or abstract, books, conferences, letters to 
editor, editorials. 
67 
33 articles published before 2002, or 
in language other than English 
34 




8 articles without “sarcoma” on title or abstract 
 
14 articles with experimental or clinical studies 
46 




5 articles without “sarcoma” on title or abstract 
 
3 articles with experimental or clinical studies 
17 
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Page 4 of 4tions of GS rely on items which can be any sort of publi-
cation (books, conferences acts, posters, letters to editor,
editorials, etc.), including scientific articles where the key
word is cited by chance in the introduction, discussion, or
references. Indeed, unlike PM, GS does not allow a clear
selection between "Human" and "Animal" studies. Punc-
tuation characters in titles produce incorrect search
results, and authors are assigned to the wrong papers,
hence leading to erroneous additional search results.
Some of these are even provided with no comprehensible
reason. This is perhaps the primary reason why Google
Scholar returns a greater number of results than PM and
why there are many GS results which are off topic or
"false hits". These facts produce a huge numbers of cita-
tions that have to be examined one by one in order to
exclude those of no interest.
The present findings were confirmed by Falagas [1] -
who found that GS could help in retrieving even the most
obscure information, but offers results of inconsistent
accuracy - and Shultz [3], reporting that GS provided
more results than PM in 8 out of 10 test searches. Fur-
thermore according to Freeman [4], PM searches yielded
fewer total citations than GS results, but PM appeared to
be more specific than GS for locating relevant primary
literature articles for drug-related questions. In spite of
the above, Google is the search engine of choice for more
than half of all Web queries [8-10].
We found that GS searches yield more free, full-text
journal articles as compared to PM. We investigated
whether GS citations not provided by PM could be found
in Medline and discovered that most articles located in
GS were accessible from PM by searching for "Author".
Therefore the two search engines seem complemen-
tary. Since they are both free for all users, their integra-
tion could greatly improve the search of references in
medical research.
Conclusions
Citations from GS were more sensitive, while citations
from PM were more specific. Interestingly, most GS cita-
tions not provided by PM were found in the Medline
database by searching for "Author". This study focused
just on one topic. Although further studies are warranted,
PM and GS appear to be complementary and their inte-
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